Skip to main content
PCL. Inc logo

PCL. Inc — Investor Relations & Filings

Ticker · 241820 ISIN · KR7241820000 KO Manufacturing
Open in API
Filings indexed 684 across all filing types
Latest filing 2021-03-25 Regulatory Filings
Country KR South Korea
Listing KO 241820

About PCL. Inc

http://www.pclchip.com/

PCL, Inc. is a company that develops and manufactures in-vitro diagnostic (IVD) medical devices, specializing in multiplex immunodiagnosis. The company's core offering is based on its proprietary SG Cap™ Technology, a platform for creating advanced diagnostic solutions. Its product portfolio includes automated multi-immune diagnostic systems, blood testing kits, cancer screening tests, and rapid antigen kits. PCL also provides platform services, reagents, and related equipment such as desktop arrayers to the medical and diagnostic fields.

Recent filings

Filing Released Lang Actions
단일판매ㆍ공급계약체결
Regulatory Filings Classification · 95% confidence The document is a formal regulatory filing from a Korean company (PCL) announcing a 'Single Sales/Supply Contract' (단일판매ㆍ공급계약체결). It details the contract value, counterparty relationship, duration, and terms. Since this is a specific regulatory disclosure regarding a business contract that does not fit into categories like M&A, dividends, or financial reports, it falls under the general regulatory filing category.
2021-03-25 Korean
단일판매ㆍ공급계약체결
Regulatory Filings Classification · 95% confidence The document is a regulatory filing from a Korean company (PCL) regarding a 'Single Sales/Supply Contract' (단일판매ㆍ공급계약체결). This type of disclosure is a standard regulatory requirement for material contracts in the Korean market. Since it does not fit into specific categories like M&A, dividends, or financial reports, it falls under the general regulatory filing category.
2021-03-25 Korean
[기재정정]단일판매ㆍ공급계약체결
Regulatory Filings Classification · 95% confidence The document is a regulatory filing from a Korean company (PCL) regarding a 'Single Sale/Supply Contract' (단일판매ㆍ공급계약체결) and a subsequent correction (정정신고) to that contract. This type of disclosure, which details specific business contracts and amendments, does not fit into the specific categories like financial reports or shareholder meetings. Therefore, it falls under the 'Regulatory Filings' (RNS) category as a general corporate disclosure.
2021-03-25 Korean
증권발행결과(자율공시)
Share Issue/Capital Change Classification · 100% confidence The document is a formal announcement regarding the results of a securities issuance (specifically, convertible preferred shares via third-party allocation). It details the number of shares issued, the total amount raised, and the payment date. This falls under the category of capital changes and share issuance announcements.
2021-03-25 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) regarding a decision on a paid-in capital increase (유상증자결정) and includes a correction notice (정정신고). In the context of Korean regulatory filings (DART), these reports detailing capital structure changes, share issuance, and third-party allocations are classified as 'Share Issue/Capital Change' filings.
2021-03-25 Korean
단일판매ㆍ공급계약체결
Regulatory Filings Classification · 95% confidence The document is a formal regulatory filing from a Korean company (PCL) announcing a 'Single Sale/Supply Contract' (단일판매ㆍ공급계약체결). It details the contract value, counterparty relationship, duration, and terms. Since this is a specific regulatory disclosure of a material business event (contract signing) that does not fit into categories like M&A, dividends, or financial reports, it falls under the general regulatory filing category.
2021-03-23 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.